Kerala Medical Council imposes penalty on doctor for displaying misleading qualifications
The penalty followed a complaint filed by the Payyannur branch of the Indian Medical Association (IMA). An inquiry was subsequently conducted by the KSMC's ethics committee, which recommended action against the doctor. The individual in question holds an MBBS degree, along with a diploma in cardiology and a fellowship in gastrointestinal endoscopy-none of which are recognised by the KSMC.
Health experts have welcomed this decision, considering it a landmark ruling that could act as a deterrent for practitioners who mislead the public by displaying unrecognised diplomas and certificates.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
22 minutes ago
- Time of India
Age no bar: Tamil Nadu senior citizens crack NEET, seek MBBS seats under govt quota
No age bar, but rising questions Live Events Seeking MBBS under government quota A policy dilemma for officials A rare spike in older applicants (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel In a rare turn of events, three senior citizens aged 68, 67, and 60 — including two practicing lawyers — have cleared the National Eligibility cum Entrance Test (NEET) this year and applied for MBBS admissions in Tamil Nadu , surprising officials and triggering an unexpected debate in the state's medical admissions applications, submitted under a special government school quota, have created a stir among members of the state selection committee, who are now grappling with legal and procedural questions surrounding age, eligibility, and the intent of reservation National Medical Commission (NMC) removed the upper age limit for NEET in 2022, opening the door for candidates of all ages to appear for the highly competitive exam. The change, aimed at making medical education more inclusive, has led to a rise in older applicants in recent years — but never quite like this.'This year, there are many graduates and professionals aspiring for a medical or dental seat. This is the highest number of middle-age and older applicants we have seen since 2017,' said a senior official involved in the admissions confirmed that at least 25 candidates aged above 35 have applied for undergraduate medical and dental seats in the state this three senior candidates have applied for admission under Tamil Nadu's 7.5% government school quota, which offers subsidised or free MBBS seats in both government and private colleges to students who studied in state-run of the applicants have scored well enough to secure admission through the 69% reservation policy — a system unique to Tamil Nadu that factors in social and educational the applications have thrown up technical inconsistencies, particularly in the documents submitted under the special quota. Officials say that in some cases, the certificates don't conform to the current format or fail to meet the exact eligibility wording outlined in the these older applicants have met the academic requirements, the core dilemma for authorities now is whether adult graduates — who may have pursued alternate careers and now returned to education — should be allowed to avail themselves of quotas originally intended to uplift disadvantaged members of the selection committee are reportedly divided. While there is no legal barrier to senior citizens entering medical school, concerns have been raised about resource allocation, course rigour, and the effective intent of affirmative action issue may prompt a broader review of eligibility definitions in government quotas in the coming year marks the highest number of middle-aged and older candidates applying for medical and dental courses in Tamil Nadu since NEET became mandatory in 2017, officials least 25 applicants above the age of 35 are in the race, including three senior citizens aged 60 and above — a first-of-its-kind development that has drawn attention across the believe the spike may reflect a broader shift in the demographics of NEET aspirants, with graduates, professionals, and retirees now seeing medicine as a viable second career or long-deferred goal. While the trend is still nascent, it marks a significant departure from the typical profile of medical college entrants.
News18
38 minutes ago
- News18
ICMR says Indians taking too much salt, launches study to address issue
New Delhi, Jul 13 (PTI) Excessive salt consumption is fuelling a silent epidemic in India with people at increased risk of hypertension, stroke, heart disease, and kidney disorders, according to scientists from ICMR's National Institute of Epidemiology. The scientists have initiated a community-led salt reduction study to address the issue and are focusing on low sodium salt substitutes. While the World Health Organisation (WHO) recommends less than 5 grams of salt per person per day, studies show that urban Indians consume around 9.2 grams/day, and even in rural areas it is around 5.6 grams/day – both higher than recommended. One promising tool in this effort is low-sodium salt substitutes — �blends where part of the sodium chloride is replaced with potassium or magnesium salts, Dr Sharan Murali, a senior scientist at National Institute of Epidemiology (NIE) and principal investigator of the study, said. 'Lesser sodium consumption helps reduce blood pressure and improves overall heart health, making low-sodium alternatives a meaningful switch, especially for those with hypertension," Dr Murali stated. 'Just switching to low-sodium salt can lower blood pressure by 7/4 mmHg on average'�a small change with a big impact," Dr Murali said. To tackle the issue of high salt consumption, the NIE has launched a three-year intervention project in Punjab and Telangana, supported by the Indian Council of Medical Research (ICMR). The goal is to evaluate the effectiveness of structured salt reduction counselling, delivered by health workers at Health and Wellness Centres (HWCs), in reducing blood pressure and sodium intake among individuals with hypertension, senior scientist at NIE, Dr Ganesh Kumar, who is also a part of the study, said.. 'We are currently in the first year of the project, focused on baseline assessments and field preparations," Dr Kumar said. 'Counselling materials are not yet finalised; rather, we aim to co-create the intervention package with the community health workers, drawing on their experiences and incorporating their suggestions. It's not just about delivering health education – �it's about listening, understanding, and building together," Dr Murali said. To ensure interventions are grounded in reality, the NIE conducted a market survey across 300 retail outlets in Chennai to assess the availability and pricing of low-sodium salt (LSS). They found that LSS was available in only 28 per cent of retail outlets. It was seen in 52 per cent of supermarkets, but a dismal 4 per cent in small grocery shops. The price of LSS averaged Rs 5.6 per 100g, more than twice the price of normal iodised salt (Rs 2.7 per 100g). These findings highlight a critical supply-demand disconnect, Dr Murali said. 'The lower demand for low sodium salt might be leading to its lower availability – it's a proxy indicator of awareness and access," noted Dr. Murali. To spark a public conversation around salt reduction, the NIE has also recently launched the #PinchForAChange campaign on Twitter and LinkedIn through ICMR-NIE. Using infographics, facts, and simple messages, the campaign aims to raise awareness about hidden salt sources, promote low-sodium alternatives, and empower individuals to make heart-healthy choices. 'If successful, this project could lead to the integration of sustainable dietary counselling models into the existing public health system. It can bridge the gap between knowledge and action, improve health literacy, and ultimately reduce the burden of hypertension-related diseases. 'This is not just about reducing salt. It's about restoring balance in our diets, our systems, and our hearts. Together, one pinch at a time, we can create lasting change," Dr Murali added. PTI PLB DV DV view comments First Published: July 13, 2025, 12:30 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
&w=3840&q=100)
Business Standard
an hour ago
- Business Standard
Cipla to enter weight management segment in India: MD & Global CEO Vohra
Drug major Cipla is preparing to foray into the weight management segment in India, its MD and global CEO Umang Vohra has said. The Mumbai-based firm is also strengthening its presence in the central nervous system (CNS) therapeutic area, he stated in his address to shareholders in the company's Annual Report for 2024-25. "Our efforts are rooted in understanding patient needs, reducing stigma, and delivering differentiated therapies for niche is emerging as a priority area for Cipla. With a clear strategic intent, we are preparing to enter the weight management segment in India, aiming to address the rising demand for effective obesity solutions," Vohra stated. Several domestic drug firms are developing drugs for weight loss to capitalise on the growing market for obesity and diabetes management. US drugmaker Eli Lilly & Co has already launched its anti-obesity drug Mounjaro in the country. Danish firm Novo Nordisk has also launched its anti-obesity drug Wegovy, indicated for both long-term chronic weight management and reduction in risk of major adverse cardiovascular events. In the CNS segment, Cipla has successfully in-licensed Sanofi's India CNS product range, including Frisium, a leading brand in the anti-epileptic category, Vohra informed shareholders. "Building on this momentum, we aim to pursue similar in-licensing deals or acquisitions in niche indications of attention deficit hyperactivity disorder (ADHD) and Parkinson's disease," he said. The company is equally committed to addressing the global crisis of antimicrobial resistance (AMR), he added. "Our AMR portfolio is evolving from volume-based to innovation-led, with four novel products in development," Vohra said. He noted that the company's ambition is to be a global, innovation-led, patient-centric healthcare company that creates long-term value through science, empathy, and sustainability. "We will continue to invest in big brands, strategic alliances, digital infrastructure, and next-generation therapies, while remaining rooted in our founding values of care and compassion," Vohra stated. Cipla's consolidated revenue stood at Rs 27,548 crore in FY25. Its consolidated net profit rose to Rs 5,272 crore during the period.
